Yuta Maehara

Mr. Yuta Maehara


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2021 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
HSHiromichi Suzuki
Hiromichi Suzuki
YAYusaku Akashi
Yusaku Akashi
AUAtsuo Ueda
Atsuo Ueda
YKYoshihiko Kiyasu
Yoshihiko Kiyasu
YTYuto Takeuchi
Yuto Takeuchi
HIHiroichi Ishikawa
Hiroichi Ishikawa

17 September 2022 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
DTDaisuke Tamura
Daisuke Tamura
HYHirokazu Yamagishi
Hirokazu Yamagishi
YMYuji Morisawa
Yuji Morisawa
TMTakashi Mato
Takashi Mato
SNShin Nunomiya
Shin Nunomiya
HOHitoshi Osaka
Hitoshi Osaka
We aimed to validate a newly developed antigen-detecting rapid diagnostic test (Ag-RDT) for SARS-CoV-2 using anterior nasal specimens. Between February 12 and September 30, 2021, 16 patients (age range, <1 month-76 years) were enrolled, and samples were collected simultaneously from anterior nasal and nasopharyngeal sites continuously during hospitalization. The primary end points were the diagnostic accuracy of the Ag-RDT and utility of anterior nasal specimens. In total, 226 sets of paired samples were obtained. In 88.2% of specimens, the viral load was high at the nasopharyngeal site. The mean cycle threshold values for the anterior nasal and nasopharyngeal sites were 32.4 and 29.9, respectively. Using the real-time polymerase chain reaction results as a reference, the Ag-RDT showed a 100% sensitivity up to day 6 of the illness, using specimens with moderate or high viral load (cycle threshold <30) from either site. From day 7, the sensitivity was 70.4-90.6% and 83.9-84.6% for the anterior nasal and nasopharyngeal sites, respectively. The specificity remained at 100%. Our novel Ag-RDT meets the World Health Organization criteria and provides stable sensitivity and specificity and accurate results with anterior nasal specimens.

4 January 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
DTDaisuke Tamura
Daisuke Tamura
YMYuji Morisawa
Yuji Morisawa
TMTakashi Mato
Takashi Mato
SNShin Nunomiya
Shin Nunomiya
MYMasaki Yoshihiro
Masaki Yoshihiro
HOHitoshi Osaka
Hitoshi Osaka
The aim of this work is to analyze the viral titers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and respiratory syncytial virus (RSV) at the anterior nasal site (ANS) and nasopharyngeal site (NS), evaluate their virological dynamics, and validate the usefulness of a newly developed two-antigen-detecting rapid antigen diagnostic test (Ag-RDT) that simultaneously detects SARS-CoV-2 and RSV using clinical specimens. This study included 195 asymptomatic to severely ill patients. Overall, 668 specimens were collected simultaneously from the ANS and NS. The cycle threshold (Ct) values calculated from real-time polymerase chain reaction were used to analyze temporal changes in viral load and evaluate the sensitivity and specificity of the Ag-RDT. The mean Ct values for SARS-CoV-2-positive, ANS, and NS specimens were 28.8, 28.9, and 28.7, respectively. The mean Ct values for RSV-positive, ANS, and NS specimens were 28.7, 28.8, and 28.6, respectively. SARS-CoV-2 and RSV showed the same trend in viral load, although the viral load of NS was higher than that of ANS. The sensitivity and specificity of the newly developed Ag-RDT were excellent in specimens collected up to 10 days after the onset of SARS-CoV-2 infection and up to 6 days after the onset of RSV infection.

6 December 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
DTDaisuke Tamura
Daisuke Tamura
YMYuji Morisawa
Yuji Morisawa
TMTakashi Mato
Takashi Mato
SNShin Nunomiya
Shin Nunomiya
MYMasaki Yoshihiro
Masaki Yoshihiro
HOHitoshi Osaka
Hitoshi Osaka
To analyze the viral titers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and respiratory syncytial virus (RSV) at the anterior nasal site (ANS) and nasopharyngeal site (NS), evaluate their virological dynamics, and validate the usefulness of a newly developed two antigen-detecting rapid antigen diagnostic test (Ag-RDT) that simultaneously detects SARS-CoV-2 and RSV using clinical specimens. This study included 195 asymptomatic to severely ill patients. Overall, 668 specimens were collected simultaneously from the ANS and NS. The cycle threshold (Ct) values calculated from real-time polymerase chain reaction were used to analyze temporal changes in viral load and evaluate the sensitivity and specificity of the Ag-RDT. The mean Ct values for SARS-CoV-2-positive, ANS, and NS specimens were 28.8, 28.9, and 28.7, respectively. The mean Ct values for RSV-positive, ANS, and NS specimens were 28.7, 28.8, and 28.6, respectively. SARS-CoV-2 and RSV showed the same trend in viral load, although the viral load of NS was higher than that of ANS. The sensitivity and specificity of the newly developed Ag-RDT were excellent in specimens collected up to 10 days after the onset of SARS-CoV-2 infection and up to 6 days after the onset of RSV infection.